High-Risk IV Medications in Special Patient Populations edited by Sandra Kane-Gill, Joseph Dasta.
Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill – requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, adv...
Full description
Saved in: